2021 Q3 Form 10-Q Financial Statement

#000147793221008731 Filed on November 22, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q4

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $956.6K $697.4K
YoY Change
Cash & Equivalents $956.6K $697.3K $832.2K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00
Prepaid Expenses
Receivables $254.4K
Other Receivables $0.00
Total Short-Term Assets $956.6K $951.7K $832.2K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $22.47K $24.47K $28.38K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $22.47K $24.47K $28.38K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $956.6K $951.7K $832.2K
Total Long-Term Assets $22.47K $24.47K $28.38K
Total Assets $979.0K $976.2K $860.5K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.60K $14.33K $4.918K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $14.60K $14.33K $4.918K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $14.60K $14.33K $4.918K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $843.5K $838.3K $725.4K
YoY Change
Common Stock $8.099K $8.099K $10.20K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $964.5K $961.8K $855.6K
YoY Change
Total Liabilities & Shareholders Equity $979.0K $976.2K $860.5K
YoY Change

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8099119 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
956572 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
832151 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
956572 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
832151 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22474 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28378 USD
CY2021Q3 us-gaap Assets
Assets
979046 USD
CY2020Q4 us-gaap Assets
Assets
860529 USD
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
10887 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
236 USD
CY2021Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
3708 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
4682 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14595 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4918 USD
CY2021Q3 us-gaap Liabilities
Liabilities
14595 USD
CY2020Q4 us-gaap Liabilities
Liabilities
4918 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8099119 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10199119 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
8099 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
10199 USD
CY2021Q3 fjhl Common Stock To Be Issued
CommonStockToBeIssued
0 USD
CY2020Q4 fjhl Common Stock To Be Issued
CommonStockToBeIssued
90 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
131700 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
129510 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19820 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10591 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
843472 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
725403 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
964451 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
855611 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
979046 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
860529 USD
CY2021Q3 us-gaap Revenues
Revenues
97651 USD
CY2020Q3 us-gaap Revenues
Revenues
542900 USD
us-gaap Revenues
Revenues
565824 USD
us-gaap Revenues
Revenues
942965 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
81348 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
271443 USD
us-gaap Cost Of Revenue
CostOfRevenue
407903 USD
us-gaap Cost Of Revenue
CostOfRevenue
604566 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
16303 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
271457 USD
us-gaap Gross Profit
GrossProfit
157921 USD
us-gaap Gross Profit
GrossProfit
338399 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10803 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8630 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30129 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32220 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
10803 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
8630 USD
us-gaap Operating Expenses
OperatingExpenses
30129 USD
us-gaap Operating Expenses
OperatingExpenses
32220 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
5500 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
262827 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
127792 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
306179 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
295 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22312 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9723 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21674 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
5205 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
240515 USD
us-gaap Net Income Loss
NetIncomeLoss
118069 USD
us-gaap Net Income Loss
NetIncomeLoss
284505 USD
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2584 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.02
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-326 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9229 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
16025 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
2621 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
240841 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
108840 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10161039 shares
us-gaap Net Income Loss
NetIncomeLoss
118069 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2062 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
268480 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-9119 USD
us-gaap Net Income Loss
NetIncomeLoss
284505 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5794 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5798 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
0 USD
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8099119 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10161039 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9568350 shares
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-543639 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-974 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3431 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
271812 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10651 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14456 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
133540 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29501 USD
fjhl Amount Due To A Director
AmountDueToADirector
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
115302 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15375 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
832151 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31380 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
956572 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46755 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
30526 USD
CY2020Q1 fjhl Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
-17977 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
13510 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
26059 USD
CY2020Q2 fjhl Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
1626 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
30480 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58165 USD
CY2020Q3 fjhl Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
326 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
240515 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
299006 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
855611 USD
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2021Q1 fjhl Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
-7743 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
66858 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
914726 USD
CY2021Q2 fjhl Issuance Of Preferred Stock And Cancellation Of Common Stock Amount
IssuanceOfPreferredStockAndCancellationOfCommonStockAmount
0 USD
CY2021Q2 fjhl Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
1098 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
46006 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
961830 USD
CY2021Q3 fjhl Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
-2584 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
5205 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
964451 USD
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8099119 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10199119 shares
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3455 USD
us-gaap Accounts Receivable Purchase
AccountsReceivablePurchase
604566 USD
us-gaap Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage
DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
1 pure
CY2020Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
271812 USD

Files In Submission

Name View Source Status
0001477932-21-008731-index-headers.html Edgar Link pending
0001477932-21-008731-index.html Edgar Link pending
0001477932-21-008731.txt Edgar Link pending
0001477932-21-008731-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fjhl-20210930.xsd Edgar Link pending
fjhl-20210930_cal.xml Edgar Link unprocessable
fjhl-20210930_def.xml Edgar Link unprocessable
fjhl-20210930_lab.xml Edgar Link unprocessable
fjhl-20210930_pre.xml Edgar Link unprocessable
fjhl_10q.htm Edgar Link pending
fjhl_10q_htm.xml Edgar Link completed
fjhl_ex311.htm Edgar Link pending
fjhl_ex312.htm Edgar Link pending
fjhl_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending